期刊文献+

胰腺内分泌肿瘤的研究进展 被引量:4

Recent advances in understanding pancreatic endocrine tumors
下载PDF
导出
摘要 胰腺内分泌肿瘤(pancreati cendocrine tumors,PETs)是一类少见肿瘤,发病率约占总人口的4-5/100万,占胰腺肿瘤的1%-2%,病程缓慢,最终发生转移致死.根据其临床表现,PETs分为功能性和无功能性两类.CD10、CD44、CD99、p27、COX2、Ki-67、KIT、CK19、ARHI、RUNX1T1、survivin等基因表达异常、染色体杂合缺失、抑癌基因甲基化及Ghrelin过度表达等因素在PETs的发病机制中发挥重要作用.铬粒素A(CgA)已作为PETs重要的血清学标志物.KIT和内皮蛋白是PETs新的独立预后指标.CgA的组织病理学阳性结果以及胃泌素、胰岛素原、血管活性肠肽(VIP)、胰高糖素等特异性激素检测可作为PETs的病理和定性诊断依据.此外,除标准的定位程序外,计算机断层扫描(CT)、正电子发射断层成像与计算机断层扫描(PET/CT)、磁共振成像(MRI)、超声(US)、超声内镜(EUS)、腹腔镜超声(LUS)、动态增强螺旋CT扫描、选择性动脉内刺激试验(ASVS)及生长抑素受体闪烁成像(SRS)等技术也用于PETs的定位诊断.外科手术仍是PETs治疗的首选.腹腔镜及生长抑素类似物也已常规应用.上述最新进展为PETs的早期诊断和治疗提供了新的思路. Pancreatic endocrine tumors(PETs) are uncommon and have an incidence of approximately 4-5 per 1 000 000 people,accounting for 1%-2% of all pancreatic neoplasms.They usually grow slowly,eventually metastasize and lead to death.PETs can be classified as functioning or non-functioning tumors based on clinical manifestation.The pathogenesis of PETs may involve abnormal expression of CD10,CD44,CD99,p27,COX2,Ki-67,KIT,CK19,ARHI,RUNX1T1,and survivin genes,loss of heterozygosity on chromosomes,hypermethylation of tumor suppressor genes,and overexpression of ghrelin.Chromogranin A(CgA) has long been used as an important broad-spectrum marker for the identif ication of PETs.KIT and endoglin are new independent prognostic markers for PETs.The diagnosis is based on histopathology demonstrating neuroendocrine features such as positive staining for chromogranin A and specifichormones such as gastrin,proinsulin,vasoactive intestinal peptide(VIP) and glucagon.In addition to standard localization procedures,radiology diagnosis including computed tomography(CT),positron emission tomography and computed tomography(PET/CT),magnetic resonance imaging(MRI),ultrasound(US),endoscopic ultrasound(EUS),laparoscopic ultrasound(LUS),dynamic enhanced spiral CT,selective arterial stimulation and venous sampling(ASVS),and somatostatin receptor scintigraphy(SRS) are performed.Surgery is still one of the cornerstones in the management of PETs.Laparoscopy,and drugs of somatostatin analogs are routinely used.Understanding of the recent advances of PETs has important implications for the early diagnosis and treatment of PETs.
作者 黄颖秋
出处 《世界华人消化杂志》 CAS 北大核心 2011年第15期1541-1549,共9页 World Chinese Journal of Digestology
关键词 胰腺内分泌肿瘤 发病机制 诊断 治疗 肿瘤标志物 生长抑素受体 Pancreatic endocrine tumors Pathogenesis Diagnosis Therapy Tumor markers Somatostatin receptor
  • 相关文献

参考文献7

二级参考文献217

  • 1Ai-Min Xu,Hong-Yan Cheng,Wen-Bin Jiang,Dong Chen,Yu-Chen Jia,Meng-Chao Wu the Department of Radiology, Eastern Hepatobiliary Surgery Hospital, Shanghai 200438, China.Multi-slice three-dimensional spiral CT cholangiography: a new technique for diagnosis of biliary diseases[J].Hepatobiliary & Pancreatic Diseases International,2002,1(4):595-603. 被引量:22
  • 2Michael Hocke,Ewald Schulze,Peter Gottschalk,Theodor Topalidis,Christoph F Dietrich.Contrast-enhanced endoscopic ultrasound in discrimination between focal pancreatitis and pancreatic cancer[J].World Journal of Gastroenterology,2006,12(2):246-250. 被引量:43
  • 3Steffen Rickes,Klaus Mnkemüller,Peter Malfertheiner.Echo-enhanced ultrasound with pulse inversion imaging: A new imaging modality for the differentiation of cystic pancreatic tumours[J].World Journal of Gastroenterology,2006,12(14):2205-2208. 被引量:10
  • 4Anlauf M,Sipos B,Kloppel G.[Tumors of the endocrine pancreas] Pathologe 2005; 26:46-51.
  • 5Gulec SA,Baum R.Radio-guided surgery in neuroendocrine tumors.J Surg Oncol 2007; 96:309-315.
  • 6Kwekkeboom DJ,de Herder WW,Kam BL,van Eijck CH,van Essen M,Kooij PP,Feelders RA,van Aken MO,Krenning EP.Treatment with the radiolabeled somatostatin analog[177 Lu-DOTA 0,Tyr3]octreotate:toxicity,efficacy,and survival.J Clin Oncol 2008; 26:2124-2130.
  • 7Muros MA,Varsavsky M,Iglesias Rozas P,Valdivia J,Delgado JR,Forrer F,Bodei L,Paganelli G.Outcome of treating advanced neuroendocrine tumours with radiolabelled somatostatin analogues.Clin Transl Oncol 2009; 11:48-53.
  • 8O'Grady HL,Conlon KC.Pancreatic neuroendocrine tumours.Eur J Surg Oncol 2008; 34:324-332.
  • 9Nomura N,Fujii T,Kanazumi N,Takeda S,Nomoto S,Kasuya H,Sugimoto H,Yamada S,Nakao A.Nonfunctioning neuroendocrine pancreatic tumors:our experience and management.J Hepatobiliary Pancreat Surg 2009; 16:639-647.
  • 10Jamar F,Barone R,Mathieu I,Walrand S,Labar D,Carlier P,de Camps J,Schran H,Chen T,Smith MC,Bouterfa H,Valkema R,Krenning EP,Kvols LK,Pauwels S.86Y-DOTA0)-D-Phe1-Tyr3-octreotide (SMT487)--a phase 1 clinical study:pharmacokinetics,biodistribution and renal protective effect of different regimens of amino acid coinfu sion.Eur J Nucl Med Mol Imaging 2003; 30:510-518.

共引文献27

同被引文献23

  • 1Takehiro Okabayashi,Yasuo Shima,Tatsuaki Sumiyoshi,Akihito Kozuki,Satoshi Ito,Yasuhiro Ogawa,Michiya Kobayashi,Kazuhiro Hanazaki.Diagnosis and management of insulinoma[J].World Journal of Gastroenterology,2013,19(6):829-837. 被引量:89
  • 2陈原稼,梅玫.胰腺内分泌肿瘤临床、分子生物学和遗传学预后指标[J].胰腺病学,2004,4(3):182-186. 被引量:4
  • 3Shimon Efrat, Susanne Linde, Hans Kofod, et al. Beta-cell lines derived from transgenic mice expressing a hybrid insulin gene oncogene[J].Cell Biology, 1988, 12(85) : 9037 -9041.
  • 4吴秉铨,刘彦仿.免疫组织化学病理诊断[M].北京:科学技术出版社,2009:310-317.
  • 5Oberg K. Pancreatic endocrine tumors[ J ]. Semin Oncol, 2010, 37:594 -618.
  • 6Varsha Babu, Navin Paul, Run Yu. Animal models and cell Lines of pancreatic neuroendocrine tumors[ J]. Pan- creas, 2013, 42(6) : 912 -923.
  • 7Jonkers Y M H, Ramaekers F C S, Speel E J M. Molec- ular alterations during insulinoma tumorigenesis [J]. Biochimica et Biophysica Acta, 2007, 1775 : 313 - 332.
  • 8Gabriele Capurso, Stefano Festa, Roberto Valente, etal. Molecular pathology and genetics of pancreatic endo- crine turnouts [ J ]. Journal of Molecular Endocrinology. 2012, 49(1) : R37 -50.
  • 9Jianliang Zhang, Rony Francois, Renuka lyer, et al. Current understanding of the molecular hiology of pancre- atic neuroendocrine tumors [ J ]. Journal of the National Cancer Institute, 2013, 105(14) : 1005 -1017.
  • 10Birnbaum D J, Gaujoux S, Cherif R, et al. Sporadic nonfunctioning pancreatic neuroendocrine tumors: prog- nostic significance of incidental diagnosis [ J ]. Surgery. 2014, 155(1): 13-21.

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部